About Biofisica
Biofisica is a company based in Atlanta (United States) founded in 2000 by Rafael Andino. It operates as a B2B. Biofisica has raised $7.3 million across 3 funding rounds from investors including Novartis, ATDC and Unilever Ventures. Biofisica operates in a competitive market with competitors including Piomic, Sky Medical Technology, Celleration, Intelligent Implants and Vomaris Innovations, among others.
- Headquarter Atlanta, United States
- Founders Rafael Andino
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$7.3 M (USD)
in 3 rounds
-
Latest Funding Round
$2.3 M (USD), Series A
Apr 21, 2008
-
Investors
Novartis
& 3 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Biofisica
Biofisica has successfully raised a total of $7.3M across 3 strategic funding rounds. The most recent funding activity was a Series A round of $2.3 million completed in April 2008. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Biofisica
Biofisica has secured backing from 4 investors, including institutional and venture fund investors. Prominent investors backing the company include Novartis, ATDC and Unilever Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
ATDC is recognized as a leading technology startup incubator.
|
Locked | Locked | Locked | |
|
Corporate-backed venture capital firm focused on consumer tech and multiple sectors
|
Locked | Locked | Locked | |
|
Venture debt and equity financing is offered to US startups.
|
Locked | Locked | Locked |
Investor details for Biofisica
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Biofisica
Investment portfolio details for Biofisica
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Biofisica
Detailed financials for Biofisica
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Biofisica Comparisons
Peer comparison for Biofisica
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Biofisica
Biofisica operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Piomic, Sky Medical Technology, Celleration, Intelligent Implants and Vomaris Innovations, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
A non-invasive electroceutical device for chronic wound treatment is developed.
|
|
| Locked | Locked | Locked |
Electro-stimulation devices are manufactured for deep vein thrombosis treatment.
|
|
| Locked | Locked | Locked |
Ultrasound technology for wound healing is developed and marketed.
|
|
| Locked | Locked | Locked |
Develops smart implants to accelerate and monitor bone growth in orthopedics.
|
|
| Locked | Locked | Locked |
Bio-mimicking microcurrent technology is applied to wound healing.
|
Detailed competitors of Biofisica
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Biofisica
Complete news archive for Biofisica
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Biofisica
Biofisica was founded in 2000 and raised its 1st funding round 6 years after it was founded.
Biofisica is headquartered in Atlanta, United States. It is registered at Atlanta, Georgia, United States.
Rafael Andino is the current CEO of Biofisica. They have also founded this company.
Biofisica is a funded company, having raised a total of $7.3M across 3 funding rounds to date.
Biofisica, based in Atlanta, focuses on providing healthcare solutions, developing medical devices, wound care, and electrical stimulation. Develops electrical stimulation devices to promote wound healing. The company prioritizes operational excellence, innovation, and customer-centric approaches for success. It continues to evolve, meeting industry challenges with strategic approaches.
Biofisica's top competitors include Sky Medical Technology, Piomic and BioElectronics Corporation.
Biofisica has 4 investors. Key investors include Novartis, ATDC, Unilever Ventures, and Leader Ventures.